COVID-19: Examining the blood components of infected people: Technology for predicting aggravation
Category: disease
COVID-19: Kitasato University begins clinical trial of ivermectin: Registration: jRCT2031200120
COVID-19: Demonstration of virus inactivating effect: Care222TM UV
FDA: Priority screening designation for Aducanumab: Alzheimer’s disease drug
COVID-19: Actemra of Roche shows no efficacy in severe cases: Overseas Phase 3 clinical trial